ALYREF expression was significantly related to Tumor mutational burden (TMB) in four cancer types (3 positively related) (Fig. 4e) and to Microsatellite Instability (MSI) in three tumors (2 positively related) (Fig. 4f). Here, ALYREF is linked to neoplasm.